2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Selected funding rounds

Date Company Profile Round
Somaxon Pharmaceuticals Inc N/A
Alkermes Inc N/A
Pharma Marketing Ltd N/A
Evalve Inc N/A
Point Biomedical Inc Developer of a microsphere that freely circulates when injected into the bloodstream. N/A
Inhibitex Inc N/A
Inviragen Inc N/A
Predictive Biosciences Inc N/A
Sonic Innovations Inc N/A
Nextwave Pharmaceuticals Inc Specialty pharmaceutical company, focused on pediatric neurology. N/A
Itero Biopharmaceuticals LLC Drug development, focused on bio-better versions of approved biologic drugs N/A
Xention Ltd N/A
Dura Pharmaceuticals Inc N/A
The Spectranetics Corp N/A
Plethora Solutions Holdings PLC Discovering and developing urological products. IPO in March 2005. N/A
Etiologics Ltd Developer of therapies for chronic respiratory disease N/A
Q Chip Ltd N/A
Orexigen Therapeutics Inc N/A
GlobeImmune Inc Biopharmaceuticals company. N/A

Pages

Selected companies

Company type: 
Personalized medicine company specializing in pharmacogenetics
Company type: 
Switzerland-based drug company focused on CNS disorders
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products